Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Cosmo Pharmaceuticals N.V.    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 1 8821 1691 0331 145--
Entreprise Value (EV)1 1 7149789301 0941 1061 106
P/E ratio -57,1x-65,0x-42,3x-135x-122x90,5x
Yield 1,20%----1,89%
Capitalization / Revenue 28,0x17,8x16,5x21,6x17,7x14,8x
EV / Revenue 25,5x14,9x14,9x20,6x17,1x14,3x
EV / EBITDA -283x-80,6x-142x119x84,4x37,3x
Price to Book 3,94x2,61x2,60x3,14x3,27x-
Nbr of stocks (in thousands) 15 03715 00214 62314 463--
Reference price (EUR) 12577,970,679,279,279,2
Last update 03/26/201803/29/201904/03/202008/03/202008/03/2020-
1 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 67,265,662,553,164,877,3
EBITDA1 -6,06-12,1-6,559,2013,129,7
Operating profit (EBIT)1 -15,5-16,6-12,33,176,8022,8
Operating Margin -23,0%-25,3%-19,7%5,96%10,5%29,4%
Pre-Tax Profit (EBT)1 -32,4-17,5-21,3-9,21-9,7813,0
Net income1 -32,4-18,1-24,5-8,53-9,9512,5
Net margin -48,3%-27,5%-39,2%-16,1%-15,3%16,2%
EPS2 -2,19-1,20-1,67-0,59-0,650,88
Dividend per Share2 1,50----1,50
Last update 03/26/201803/29/201904/03/202010/24/202010/24/202010/24/2020
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 ------
Net Cash position1 16819110351,039,039,0
Leverage (Debt / EBITDA) 27,7x15,8x15,8x-5,54x-2,98x-1,32x
Free Cash Flow1 -22,3-12,1-21,1-24,0-5,008,00
ROE (Net Profit / Equities) --3,95%-5,83%6,00%11,0%23,0%
Shareholders' equity1 -457420-142-90,554,3
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 31,729,927,125,224,2-
Cash Flow per Share -0,68-0,68----
Capex1 12,31,902,251,802,051,70
Capex / Sales 18,3%2,89%3,59%3,39%3,16%2,20%
Last update 03/26/201803/29/201904/03/202011/24/202011/24/202011/24/2020
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (CHF)
1 242 386 388
Capitalization (USD)
1 370 893 991
Net sales (EUR)
62 495 000
Net sales (USD)
74 832 138
Number of employees
261
Sales / Employee (EUR)
239 444
Sales / Employee (USD)
286 713
Free-Float
45,8%
Free-Float capitalization (CHF)
569 199 007
Free-Float capitalization (USD)
628 074 732
Avg. Exchange 20 sessions (EUR)
870 856
Avg. Exchange 20 sessions (USD)
1 042 771
Average Daily Capital Traded
0,07%
EPS & Dividend